IRCT20150817023666N9招募中3 期
The effects of cabergoline in reducing the size of endometrioma endometriosis
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 45 years（—）
- 性别
- Female
入选标准
- •one-sided endometrioma
- •Size less than 5 cm
- •No ultrasound criteria for malignancy
- •The absence of laboratory criteria for malignancy
- •Have informed consent to enter the study
- •Maximum 45 years
排除标准
- •Hormonal treatment includes Contraceptive 3 months before entering the study
- •Cabergolin sensitivity
研究者
相似试验
已完成
3 期
Treatment of uterine myoma.fibromyoma of uterus.Leiomyoma of uterusfibromyoma of uterusIRCT201403092624N12Vice chancellor for research ,Iran University of Medical Sciences.50
尚未招募
Unknown
Comparison of the effect of Cabergoline versus Dienogest on markers in endometriosisCTRI/2023/04/051886il
已完成
不适用
Assigning the effect of administration of cabergoline on uterine perfusion in women with polycystic ovary syndromeIRCT201009154755N1Kurdistan University of Medical Sciences40
招募中
3 期
The effect of Cabergoline on blood glucose control in type 2 diabetic patientsIRCT20100314003565N9Tabriz University of Medical Sciences50
已完成
不适用
Investigation of the effect of empagliflozin on cardiac sympathetic and parasympathetic nerve activity in Japanese patients with type 2 diabetesDiabetes Mellitus (type 2)JPRN-UMIN000029194Shinshu University School of Medicine112